We have a suspicion that you are an automated web bot software, not a real user. To keep our site fast for other users, we have slowed down this page. The slowdown will gradually disappear. If you think this is a mistake, please contact us at genome-www@soe.ucsc.edu. Also note that all data for hgGeneGraph can be obtained through our public MySQL server and all our software source code is available and can be installed locally onto your own computer. If you are unsure how to use these resources, do not hesitate to contact us.
UCSC Genome Browser Gene Interaction Graph
Gene interactions and pathways from curated databases and text-mining

◀ Back to CASP9

CASP9 — CTSB

Text-mined interactions from Literome

Knoblach et al., J Cereb Blood Flow Metab 2004 (Brain Injuries...) : Neither the 120 kD caspase mediated alpha-spectrin cleavage product nor cathepsin B were expressed after maitotoxin injury
Guicciardi et al., Gastroenterology 2005 : These data suggest that tumor necrosis factor alpha triggers Bid dependent lysosomal permeabilization, followed by release of cathepsin B into the cytosol and activation of caspase 2
Ben-Ari et al., Apoptosis 2005 (Reperfusion Injury) : Recently, it was demonstrated that the release of cathepsin B , a cysteine protease, from the cytosol in liver injury induces mitochondrial release of cytochrome c and the activation of caspase-3 and -9, thereby leading to apoptosis
Yeung et al., J Biol Chem 2006 (Pancreatic Neoplasms) : PS-341 induced caspase-2 activation was attenuated by a selective pharmacological inhibitor of cathepsin B ( R-3032 ), suggesting that cathepsin B release occurs upstream of caspase-2
Paris et al., Apoptosis 2007 : A cathepsin B/L inhibitor partially suppresses caspase activation and apoptosis induction, indicating signaling between lysosomes and mitochondria
Huang et al., J Pharmacol Exp Ther 2009 : Taken together, we show that GSK-3beta exhibits a mechanism of ER stress induced lysosomal apoptosis in leukemia involving caspase-2 induced LMP and cathepsin B relocation, which result in caspase-8 and -3 activation
Zheng et al., PloS one 2012 (Necrosis...) : IL-1ß secretion was reduced in the presence of cathepsin B inhibitors, suggesting that activation of caspase-1 requires cathepsin B activity
Sun et al., J Neurosci 2012 (Chronic Pain...) : There is increasing evidence that cathepsin B (CatB) , a typical lysosomal cysteine protease, is involved in the pro-caspase-1 activation and the subsequent maturation of IL-1ß and IL-18
Morchang et al., Biochem Biophys Res Commun 2013 : Treatment with cathepsin B inhibitor also reduced the activity of caspase 9, suggesting that cathepsin B activates both caspase-9 and caspase-3
Jones et al., Am J Physiol 1998 (Liver Neoplasms, Experimental) : Our data demonstrate that 1 ) bile salt induced apoptosis can be inhibited by the cystatin A transgene and 2 ) caspase and cathepsin B activation are linked mechanistically with cathepsin B downstream of caspases
Schotte et al., Biochem Biophys Res Commun 1998 (Inflammation) : Cathepsin B-mediated activation of the proinflammatory caspase-11
Vancompernolle et al., FEBS Lett 1998 : All newly described activities of cathepsin B , namely processing of caspase zymogens and induction of nuclear apoptosis, are inhibited by the synthetic peptide caspase inhibitors z-VAD.fmk, z-DEVD.fmk and to a lesser extent by Ac-YVAD.cmk
Schotte et al., FEBS Lett 1999 : In addition, the caspase inhibitors z-VAD.fmk, z-DEVD.fmk and Ac-YVAD.cmk also efficiently inhibited cathepsin B activity in vitro and in tissue culture cells at concentrations that are generally used to demonstrate the involvement of caspases